Lowering inflammation through lipid-lowering therapy: are we there yet?-Reference-Cited by-同舟云学术

Lowering inflammation through lipid-lowering therapy: are we there yet?

Published:2020-01-08 Issue:2 Volume:6 Page:93-94
ISSN:2058-5225
Container-title:European Heart Journal - Quality of Care and Clinical Outcomes
language:en
Short-container-title:

Author:

Agarwal Nayan¹,Golwala Harsh²

Affiliation:

1. Department of Medicine, Division of Cardiology, Cardiovascular Institute of the South, 6550 Main Street, Zachary, LA 70791, USA

2. Department of Medicine, Knight Cardiovascular Institute, Oregan Health and Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Health Policy

Link

http://academic.oup.com/ehjqcco/advance-article-pdf/doi/10.1093/ehjqcco/qcz068/31868422/qcz068.pdf

Reference13 articles.

1. Antiinflammatory therapy with canakinumab for atherosclerotic disease;Ridker;N Engl J Med,2017

2. Atherosclerosis—an inflammatory disease;Ross;N Engl J Med,1999

3. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms;Jain;Nat Rev Drug Discov,2005

4. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study;Albert;JAMA,2001

5. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein;Ridker;N Engl J Med,2008

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methionine strengthens anti-inflammation of rice protein via depressing NF-κB activation and stimulating Msr expression in rats fed cholesterol-enriched diets;Food Science and Biotechnology;2022-04-11